Women’s health is emerging as one of the most compelling growth frontiers in life sciences and healthcare—and New York City is at the center of that momentum.
Long treated as a niche category, women’s health is now understood as the study of diseases and conditions that not only uniquely affect women, but also disproportionately or differently affect women, making women's health a potential $100B market opportunity.
A new report from the New York City Economic Development Corporation (NYCEDC) provides a comprehensive analysis of why New York City is uniquely positioned to lead. With world-class research and medical institutions, supportive policies for women workers and entrepreneurs, and a collaborative innovation ecosystem, NYC has the strengths to advance solutions in women’s health where evidence gaps are largest and market opportunities most underdeveloped.
New York City has become one of the most important places where this opportunity is being built, with 1 in 6 U.S. women's health founders based in NYC and 1 in 20 U.S. women's health companies based here.
— Monica Malowney, NYCEDC
Learn more: https://lifesci.nyc/womens-health.
Read the full paper: https://edc.nyc/sites/default/files/2026-05/LifeSci-NYC-Womens-Health-Innovation-In-NYC.pdf.
